论文部分内容阅读
目的观察布地奈德雾化吸入治疗小儿支气管哮喘急性发作的效果。方法 60例患儿随机分成对照组和观察组,每组30例,对照组给予常规抗感染、扩张支气管及静脉滴注氢化可的松治疗,观察组在对照组基础上加用雾化吸入布地奈德混悬液0.5 mg治疗,2次/d,3 d为1个疗程。结果观察组总有效率96.66%,对照组总有效率80.00%,两组比较差异有统计学意义(P<0.05);观察组咳嗽、喘息、肺部喘鸣音等症状及体征消失时间均明显短于对照组(P<0.01),且住院时间也明显少于对照组(P<0.05)。结论布地奈德雾化吸入治疗能提高小儿支气管哮喘急性发作期常规治疗的疗效,加速支气管哮喘患儿康复,值得推广应用。
Objective To observe the effect of inhalation of budesonide in the treatment of acute attack of bronchial asthma in children. Methods 60 cases of children were randomly divided into control group and observation group, 30 cases in each group. The control group was given routine anti-infective, bronchial expansion and intravenous infusion of hydrocortisone treatment. The observation group was treated with nebulized budesonide Ned suspension 0.5 mg treatment, 2 times / d, 3 d for a course of treatment. Results The total effective rate was 96.66% in the observation group and 80.00% in the control group, with significant difference between the two groups (P <0.05). The symptom such as cough, wheezing and pulmonary wheeze in the observation group and the disappearance time of the signs were obvious Shorter than the control group (P <0.01), and hospitalization time was also significantly less than the control group (P <0.05). Conclusion Budesonide inhalation therapy can improve the efficacy of routine treatment in children with acute exacerbation of bronchial asthma and accelerate the recovery of children with bronchial asthma, which is worth popularizing and applying.